Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain
| Autor: | Thomas Ernst, Stephanie D. Kraft-Terry, Linda Chang, Sody Munsaka |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Pathology
medicine.medical_specialty Magnetic Resonance Spectroscopy Immunology Neuroscience (miscellaneous) Article chemistry.chemical_compound medicine Immunology and Allergy Choline Animals Humans Neuroinflammation Pharmacology Inflammation Neurons Microglia business.industry Multiple sclerosis Chronic pain Glutamate receptor Methamphetamine medicine.disease medicine.anatomical_structure chemistry nervous system Neuropathic pain Neuralgia business Neuroscience medicine.drug |
| Popis: | Proton magnetic resonance spectroscopy ((1)H MRS) has been applied to numerous clinical studies, especially for neurological disorders. This technique can non-invasively evaluate brain metabolites and neurochemicals in selected brain regions and is particularly useful for assessing neuroinflammatory disorders. Neurometabolites assessed with MRS include the neuronal markers N-acetylaspartate (NAA) and glutamate (Glu), as well as the glial marker myo-inositol (MI). Therefore, the concentrations of these metabolites typically correspond to disease severity and often correlate well with clinical variables in the various brain disorders. Neuroinflammation with activated astrocytes and microglia in brain disorders are often associated with elevated MI, and to a lesser extent elevated total creatine (tCr) and choline containing compounds (Cho), which are found in higher concentrations in glia than neurons, while neuronal injury is indicated by lower than normal levels of NAA and Glu. This review summarizes the neurometabolite abnormalities found in MRS studies performed in patients with neuroinflammatory disorders or neuropathic pain, which also may be associated with neuroinflammation. These brain disorders include multiple sclerosis, neuroviral infections (including Human Immunodeficiency virus and Hepatitis C), degenerative brain disorders (including Alzheimer's disease and Parkinson's disease), stimulant abuse (including methamphetamine and cocaine) as well as several chronic pain syndromes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|